Board MeetingIBP
IBP Board to Review Q3 Results for FY 2022–23 on 25 May 2023
Announcement summary
- What happened
- IBP will hold a board meeting on 25 May 2023 at 3:30 PM to review unaudited financial statements for Q3 of FY 2022–23.
- Meeting date
- 25 May 2023
- Meeting time
- 3:30 PM
- Purpose
- consider audited financial statements
- Financial period
- Q3
- Financial year
- FY 2022–23
- Company
- Indo-Bangla Pharmaceuticals Limited
- Announcement published
Original announcement
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on May 25, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
কোম্পানিটি আরও জানিয়েছে যে ঢাকা স্টক এক্সচেঞ্জ (লিস্টিং) রেগুলেশন, 2015 এর রেগুলেশন 16(1) অনুযায়ী কোম্পানির পরিচালনা পর্ষদের সভা বিবেচনা করার জন্য 25 মে, 2023 বিকাল 3:30 টায় অনুষ্ঠিত হবে। , অন্যদের মধ্যে, 31 মার্চ, 2023-এ শেষ হওয়া তৃতীয় ত্রৈমাসিকের (Q3) সময়ের জন্য কোম্পানির অনিরীক্ষিত আর্থিক বিবৃতি।
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 646ae015a7ae9d764577373b
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBP
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.